Anika Therapeutics reported $362.25M in Assets for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acceleron Pharma XLRN:US $ 875.79M 56.54M
Acorda Therapeutics ACOR:US $ 584.05M 48.63M
Adamas Pharmaceuticals ADMS:US 120.03M 12.77M
Agenus AGEN:US $ 234.92M 20.4M
Agios Pharmaceuticals AGIO:US $ 2488.43M 1635.48M
Anika Therapeutics ANIK:US $ 362.25M 3.35M
Arrowhead Research ARWR:US $ 756.8M 257.54M
Chemocentryx CCXI:US $ 499.11M 19.79M
Clovis Oncology CLVS:US $ 548.84M 56.72M
Dicerna Pharmaceuticals DRNA:US $ 683.41M 24.44M
Enanta Pharmaceuticals ENTA:US $ 467.77M 13.24M
Halozyme Therapeutics HALO:US $ 579.92M 55.9M
Heron Therapeutics HRTX:US $ 310.93M 42.62M
Immunogen IMGN:US $ 355.07M 107.12M
Insmed INSM:US $ 692.39M 103.76M
Integra Lifesciences IART:US $ 3741.55M 126.42M
Johnson & Johnson JNJ:US $ 172557M 2337M
Karyopharm Therapeutics KPTI:US $ 274.91M 38.14M
Ligand Pharmaceuticals LGND:US $ 1295.12M 67.16M
Macrogenics MGNX:US $ 435.44M 56.7M
Merit Medical Systems MMSI:US $ 1651.72M 12.68M
Rigel Pharmaceuticals RIGL:US $ 215.99M 105.62M
Sangamo Biosciences SGMO:US $ 877.1M 61.46M
Stryker SYK:US $ 33455M 875M
Surmodics SRDX:US $ 177.1M 13.54M
Veracyte VCYT:US $ 457.16M 3.01M
Xencor XNCR:US $ 692.74M 10.51M
Zimmer Biomet Holdings Inc ZBH:US $ 24.03B 391.1M